Company intelligence
Axiom Biosciences
Axiom Biosciences (formerly Cytonus Therapeutics).
About Axiom Biosciences
Axiom Biosciences (formerly Cytonus Therapeutics) is a clinical-stage biotechnology company developing next-generation regenerative therapies and targeted biologics. Through advanced cellular engineering and translational science, the company is building a pipeline of therapies designed to address some of the most challenging diseases across neurology, inflammation, and regenerative medicine. Founded in 2018 and headquartered in San Diego, California, Axiom is advancing programs from rare pediatric conditions toward larger indications, including adult ischemic stroke. To learn more, please visit www.axiombio.co.
Verified activity
Signals from Axiom Biosciences
2 published signals
Products & Services
Axiom Biosciences builds its programs across four platforms: stem cells, nanoparticles, mRNA and fusion proteins.
Reported by Axiom Biosciences
Products & Services
Axiom Biosciences brings together established therapeutic platforms with AI-enabled drug design to develop highly targeted therapies designed to interact directly with the body's molecular and cellular systems.
Reported by Axiom Biosciences